Sara Lemoinne

3.5k total citations · 1 hit paper
41 papers, 1.9k citations indexed

About

Sara Lemoinne is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Sara Lemoinne has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hepatology, 25 papers in Epidemiology and 20 papers in Surgery. Recurrent topics in Sara Lemoinne's work include Liver Diseases and Immunity (24 papers), Liver Disease Diagnosis and Treatment (23 papers) and Gallbladder and Bile Duct Disorders (13 papers). Sara Lemoinne is often cited by papers focused on Liver Diseases and Immunity (24 papers), Liver Disease Diagnosis and Treatment (23 papers) and Gallbladder and Bile Duct Disorders (13 papers). Sara Lemoinne collaborates with scholars based in France, Italy and United Kingdom. Sara Lemoinne's co-authors include Chantal M. Boulanger, Pierre‐Emmanuel Rautou, Dominique Valla, Richard Moreau, Johanne Poisson, François Durand, Chantal Housset, Dominique Thabut, Christophe Corpechot and Olivier Chazouillères and has published in prestigious journals such as Hepatology, Gut and Journal of Hepatology.

In The Last Decade

Sara Lemoinne

35 papers receiving 1.9k citations

Hit Papers

Liver sinusoidal endothelial cells: Physiology and role i... 2016 2026 2019 2022 2016 200 400 600

Peers

Sara Lemoinne
Myeong Jun Song South Korea
Qiang Zhu China
Imad Nasser United States
Sae Hwan Lee South Korea
Lydia M. Petrovic United States
Myeong Jun Song South Korea
Sara Lemoinne
Citations per year, relative to Sara Lemoinne Sara Lemoinne (= 1×) peers Myeong Jun Song

Countries citing papers authored by Sara Lemoinne

Since Specialization
Citations

This map shows the geographic impact of Sara Lemoinne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Lemoinne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Lemoinne more than expected).

Fields of papers citing papers by Sara Lemoinne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Lemoinne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Lemoinne. The network helps show where Sara Lemoinne may publish in the future.

Co-authorship network of co-authors of Sara Lemoinne

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Lemoinne. A scholar is included among the top collaborators of Sara Lemoinne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Lemoinne. Sara Lemoinne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corpechot, Christophe, Karima Ben Belkacem, Farid Gaouar, et al.. (2025). Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study. JHEP Reports. 7(11). 101546–101546.
2.
Santos, Andrey, Dioze Guadagnini, Haquima El Mourabit, et al.. (2024). Impact of cholecystectomy on the gut-liver axis and metabolic disorders. Clinics and Research in Hepatology and Gastroenterology. 48(7). 102370–102370. 1 indexed citations
3.
Andréani, Tony, et al.. (2024). Unexplained Chronically Elevated Aminotransferases: Liver Biopsy Gives Major Information with Therapeutic Implication in One Patient Out of Seven. Digestive Diseases and Sciences. 70(3). 1178–1189. 1 indexed citations
4.
Corpechot, Christophe, Dong Chen, Aymeric Becq, et al.. (2024). Endoscopic features of low-phospholipid-associated cholelithiasis syndrome: A retrospective cohort study. Clinics and Research in Hepatology and Gastroenterology. 48(5). 102324–102324.
5.
Willemse, José, Martine Walmsley, Natalie Uhlenbusch, et al.. (2024). WED-158-YI Disease experience and care expectations in european patients with immune-mediated liver disease. Journal of Hepatology. 80. S712–S712. 1 indexed citations
6.
Trinh, Vincent Quoc‐Huy, Ting‐Fang Lee, Sara Lemoinne, et al.. (2023). Hepatic stellate cells maintain liver homeostasis through paracrine neurotrophin-3 signaling that induces hepatocyte proliferation. Science Signaling. 16(787). eadf6696–eadf6696. 23 indexed citations
7.
Cazzagon, Nora, S. El Mouhadi, Carlos Ferreira, et al.. (2022). Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis. JHEP Reports. 4(11). 100577–100577. 15 indexed citations
8.
Cazzagon, Nora, Ester Gonzalez‐Sanchez, Dominique Wendum, et al.. (2022). Protective potential of the gallbladder in primary sclerosing cholangitis. JHEP Reports. 5(4). 100649–100649. 6 indexed citations
9.
Corpechot, Christophe, S. El Mouhadi, Véronique Barbu, et al.. (2022). ABCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome. JHEP Reports. 4(11). 100590–100590. 8 indexed citations
10.
Lemoinne, Sara, Alexandra Heurgué, Jérôme Gournay, et al.. (2021). Non-invasive diagnosis and follow-up of autoimmune hepatitis. Clinics and Research in Hepatology and Gastroenterology. 46(1). 101772–101772. 4 indexed citations
11.
Cazzagon, Nora, Olivier Chazouillères, Christophe Corpechot, et al.. (2019). Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis. Clinics and Research in Hepatology and Gastroenterology. 43(4). 387–394. 7 indexed citations
12.
Lemoinne, Sara, Astrid Kemgang, Karima Ben Belkacem, et al.. (2019). Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut. 69(1). 92–102. 146 indexed citations
13.
Lemoinne, Sara & Scott L. Friedman. (2019). New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases. Current Opinion in Pharmacology. 49. 60–70. 49 indexed citations
14.
Cazzagon, Nora, Christophe Corpechot, S. El Mouhadi, et al.. (2018). Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis. European Radiology. 29(3). 1460–1468. 5 indexed citations
15.
Loeuillard, Emilien, Haquima El Mourabit, Lin Lei, et al.. (2018). Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(12). 3688–3696. 18 indexed citations
16.
Poisson, Johanne, Sara Lemoinne, Chantal M. Boulanger, et al.. (2016). Liver sinusoidal endothelial cells: Physiology and role in liver diseases. Journal of Hepatology. 66(1). 212–227. 743 indexed citations breakdown →
17.
Lemoinne, Sara, Dominique Thabut, Chantal Housset, et al.. (2014). The emerging roles of microvesicles in liver diseases. Nature Reviews Gastroenterology & Hepatology. 11(6). 350–361. 143 indexed citations
18.
Lemoinne, Sara, Axelle Cadoret, Haquima El Mourabit, Dominique Thabut, & Chantal Housset. (2013). Origins and functions of liver myofibroblasts. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1832(7). 948–954. 105 indexed citations
20.
Lemoinne, Sara & Dominique Thabut. (2012). Screening for esophageal varices. Clinical Liver Disease. 1(5). 143–146. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026